Proliferative characterization of basal-cell carcinoma and trichoepithelioma in small biopsy specimens

Journal of Cutaneous Pathology

Volumn 31, Issue 8, 2004, Pages 550-554

  Lum, Christopher A ^a   Binder, Scott W ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CARCINOGENIC ACTIVITY; CELL CYCLE; CELL PROLIFERATION; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SKIN BIOPSY; TRICHOEPITHELIOMA;

BIOPSY; CARCINOMA, BASAL CELL; CARCINOMA, SKIN APPENDAGE; CELL CYCLE; CELL CYCLE PROTEINS; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIAGNOSIS, DIFFERENTIAL; HUMANS; KI-67 ANTIGEN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 4043077797     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00230.x     Document Type: Article

References (14)

1. Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, et al. Immunohistochemical evaluation of basal cell carcinoma and trichoepithelioma using Bcl-2, Ki67, PCNA and P53. J Cutan Pathol 2000; 27: 169.
2. Cesinaro AM, Migaldi M, Corrado S, et al. Expression of p27kip-1 in basal cell carcinomas and trichoepitheliomas. Am J Dermatopathol 2002; 24: 313.
3. Swanson PE, Fitzpatrick MM, Ritter JH, et al. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol 1998; 25: 153.
4. Kurzen H, Esposito L, Langbein L, et al. Cytokeritins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma. Am J Dermatopathol 2001; 23: 501.
5. Jimenez FJ, Burchette JL, Grichnik JM, et al. Ver-Ep4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol 1995; 8: 854.
6. Tellechea O, Reis JP, Domingues JS, et al. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 1993; 15: 452.
7. Kirchmann TT, Prieto VG, Smoller BR. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keritinocytic neoplasms. J Cutan Pathol 1995; 22: 422.
8. Smoller BR, Van De Rijn, Lebrun D, et al. bcl-2 expression reliably distinguishes trichoepriteliomas from basal cell carcinomas. Br J Dermatol 1994; 131: 23.
9. Schirren CG, Rutten A, Kaudewitz P, et al. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments. Am J Dermatopathol 1997; 19: 341.
10. Yamamoto O, Asahi M. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma. Br J Dermatol 1999; 140: 8.
11. Roninson IB. Oncogenic functions of tumour suppressor p21 (Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179: 1.
12. Lee MH, Yang HY. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol Life Sci 2001; 58: 1907.
13. McDonald ER, El-Deiry WS. Checkpoint genes in cancer. In Aalto-SetAld K, ed. Genetics of cancer. Ann Med 2001; 33: 113.
14. Staibano S, Muzio LL, Pannone G, et al. DNA ploidy and cyclin DI expression in basal cell carcinoma of the head and neck. Am J Clin Pathol 2001; 115: 805.